期刊
ORGANIC & BIOMOLECULAR CHEMISTRY
卷 20, 期 25, 页码 5076-5085出版社
ROYAL SOC CHEMISTRY
DOI: 10.1039/d2ob00717g
关键词
-
资金
- National Natural Science Foundation of China [82174161]
- Department of Education of Guangdong Province [2021ZDZX2030, 2020ZDZX2017]
- Guangdong Basic and Applied Basic Research Foundation [2021A1515110115]
- Foundation of Guangzhou Basic and Applied Basic Research [202102020548, 202102010257]
In this study, a fluorescent probe TTPy was prepared and shown to bind with human serum albumin, enabling fluorescent labeling under visible light irradiation. Competitive binding assay revealed its interaction with a group of non-steroidal anti-inflammatory drugs at their binding site.
Human serum albumin (HSA) can bind with numerous drugs, leading to a significant influence on drug pharmacokinetics as well as undesirable drug-drug interactions due to competitive binding. Probing the HSA drug binding site thus offers great opportunities to reveal drug-HSA binding profiles. In the present study, a fluorescent probe (E)-4-(2-(5-(4-(diphenylamino)phenyl)thiophen-2-yl)vinyl)-1-propylpyridin-1-ium (TTPy) has been prepared, which exhibits enhancement of deep-red to near-infrared (NIR) fluorescence upon HSA binding. The competitive binding assay indicated that TTPy can target the HSA binding site of fenamates, a group of non-steroidal anti-inflammatory drugs (NSAIDs), with moderate binding affinity (1.95 x 10(6) M-1 at 303 K). More interestingly, TTPy enables fluorescent labeling of HSA upon visible light irradiation. This study provides promising ways for HSA drug binding site identification and photochemical protein labeling.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据